"S-PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID6182076531

KRS0000300747

Share capital350,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. METALOWCÓW 39, 62-800 KALISZ

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

"S-PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. METALOWCÓW 39, 62-800 KALISZ

Show on map

NIP

6182076531

REGON

300747540

KRS

0000300747

Legal form

limited liability company

Register Address

UL. METALOWCÓW 39, 62-800 KALISZ

Date of registration in KRS

2008-03-04

Date of commencement of economic activity

2008-03-04

Act signature

PO.IX NS-REJ.KRS/6952/20/744/ADE

Pkd codes

47.73.Z - Retail sale of pharmaceutical products

21.10.Z - Manufacture of basic pharmaceutical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

47.29.Z - Retail trade

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

47.78.Z - Retail sale of other new products

49.41.Z - Road freight transport

68.10.Z - Real estate activities on own account and development of building projects

68.20.Z - Rental and management of own or leased real estate

Payer VAT status

Active

Vat list bank account(s)

PL69 1160 2202 0000 0001 0496 4135

Company authorities

representation authorityMANAGEMENT

representation type

DO REPREZENTOWANIA SPÓŁKI UPOWAŻNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

MANAGEMENT

Krzysztof Rafał Szelc

Chairman Of The Board, 46 years old

Janusz Józef Smolarek

Vice President, 49 years old

shareholders

Krzysztof Rafał Szelc

50% 350 udziałów o łącznej wysokości 175.000,00 zł

Janusz Józef Smolarek

50% 350 udziałów o łącznej wysokości 175.000,00 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	1,4	0,4	-0,2	-161,5
EBITDA	1,7	0,6	0	-97,4
Short time liabilities	5,5	4,4	4,2	-4,3
Equity capital	6,2	6,5	6,3	-2,6
Operating profit (EBIT)	1,4	0,4	-0,2	-158,2
Assets	12,1	11,1	10,6	-4,6
Net profit (loss)	1,4	0,3	-0,2	-151,8
Cash	2,6	2,7	2,2	-19,7
Net income from sale	24,1	22,7	19,6	-13,7
Liabilities and provisions for liabilities	5,9	4,6	4,3	-7,3
Working assets	7,1	6,1	5,8	-3,9
Depreciation	0,3	0,2	0,2	-0,9
	%	%	%	p.p.
Profitability of capital	22,4	5,1	-2,7	-7,8
Equity capital to total assets	51,1	58,6	59,8	1,2
Gross profit margin	5,9	1,7	-1,2	-2,9
EBITDA Margin	7,1	2,8	0,1	-2,7
	Days	Days	Days	Days
Short term commitment turnover cycle	84	71	78	7